The immunophilin FKBP12 functions as a common inhibitor of the TGFβ family type I receptors

Cell

Volumn 86, Issue 3, 1996, Pages 435-444

  Wang, Tongwen ^a   Li, Bi Yu ^a   Danielson, Paul D ^a   Shah, Paresh C ^a   Rockwell, Sybil ^a   Lechleider, Robert J ^b   Martin, Jennifer ^a   Manganaro, Thomas ^a   Donahoe, Patricia K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOPHILIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BINDING SITE; CALCIUM TRANSPORT; GENE EXPRESSION REGULATION; LIGAND BINDING; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; REGULATORY MECHANISM;

RUMEX;

EID: 0030576525     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80116-6     Document Type: Article

References (47)

1. Attisano, L., Wrana, J.L., Lopez-Castillas, F., and Massagué, J. (1994). TGF-beta receptors and actions. Biochim. Biophys. Acta 1222, 71-80.
2. Bassing, C., Yingling, J., Wang, T., Howe, D., He, W.W., Gustafson, M., Shah, P., Donahoe, P., and Wang, X.-F. (1994). Identification of a functional TGF-β type I receptor. Science 263, 87-89.
3. Becker, J.W., Rotonda, J., McKeever, B.M., Chan, H.K., Marcy, A.I., Wiederrecht, G., Hermes, J.D., and Springer, J.P. (1993). FK-506-binding protein: three-dimensional structure of the complex with the antagonist L-685,818. J. Biol. Chem. 268, 11335-11339.
4. Border, W.A., and Ruoslahti, E.J. (1992). Transforming growth factor-beta in disease: the dark side of tissue repair. J. Clin. Invest. 90, 1-7.
5. Brown, E.J., Albers, M.W., Shin, T.B., Ichikawa, K., Keith, D.T., Lane, W.S., and Schreiber, S.L. (1994). A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369, 756-758.
6. Brown, E.J., Beal, P.A., Keith, C.T., Chen, J., Bumshin, T., Schreiber, S.L. (1995). Control of p70S6 kinase activity of FKAP in vivo. Nature 377, 441-446.
7. Brummel, T.J., Twombly, V., Marqués, G., Wrana, J.L., Newfeld, M.B., Attisano, L., Massagué, J., O'Connor, M.B., and Gelbart, W.M. (1994) Characterization and relationship of Dpp receptors encoded by the saxophone and thick veins genes in Drosophila. Cell 78, 251-261.
8. 2+ flux. Cell 83, 463-472.
9. Cardenas, M.E., Hemenway, C., Muir, R.S., Ye, R., Fiorentino, D., and Heitman, J. (1994). Immunophilins interact with calcineurin in the absence of exogenous immunosuppressive ligands. EMBO J. 13, 5944-5957.
10. Clipstone, N.A., and Crabtree, G.R. (1992). Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357, 695-697.
11. Donahoe, P.K., Ito, Y., and Hendren, W.H., III. (1977). A graded organ culture assay for the detection of Müllerian Inhibiting Substance. J. Surg. Res. 23, 141-148.
12. Dumont, F.J., Staruch, M.J., Koprak, S.L., Siekierka, J.J., Lin, C.S., Harrison, R., Sewell, T., Kindt, V.M., Beattie, T.R., Wyvratt, M., and Sigal, N.H. (1992). The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin. J. Exp. Med. 176, 751-760.
13. Ebner, R., Chen, R.-H., Shum, L., Lawler, S., Zioncheck, T.F., Lee, A., Lopez, A.R, and Derynk, R. (1993). Cloning of a type I TGF-β receptor and its effect on TGF-β binding to the type II receptor. Science 260, 1344-1348.
14. Feng, X.-H., Filvaroff, E.H., and Derynck, R. (1995). Transforming growth factor-β (TGF-β)-induced down-regulation of cyclin A expression requires a functional TGF-β receptor complex. J. Biol. Chem. 270, 24237-24245.
15. Gyuris, J., Golemis, E., Chertkov, H., and Brent, R. (1993). Cdi1, a human G1 and S phase protein phosphotase that associates with Cdk2. Cell 75, 791-803.
16. Harding, M.W., Galat, A., Uehlin, D.E., and Schreiber, S.L. (1989). A receptor for the immunosuppressant FK506 is a cis-trans peptidylprolyl isomerase. Nature 341, 758-760.
17. He, W.W., Gustafson, M.L., Hirobe, S., and Donahoe, P.K. (1993). The developmental expression of four novel serine/threonine kinase receptors homologous to the Activin/TGF-β II receptor family. Dev. Dyn. 196, 133-142.
18. Jost, A. (1947). Recherches sur la differenciation sexuelle de l'embryon de lapin. Arch. Anat. Micro. Morph. Exp. 36, 271-315.
19. Kingsley, D.M. (1994). The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8, 133-146.
20. Kissinger, C.R., Parger, H.E., Knighton, D.R., Lewis, C.T., Pelletier, L.A., Tempczyk, A., Kallish, V.J., Tucker, K.D., Showalter, R.E., Moomaw, E.W., et al. (1995). Crystal structure of human calcineurin and the human FKBP12-FK506-calcineurin complex. Nature 378, 641-644.
21. Lin, H.Y., Wang, X.-F., Ng-Eaton, E., Weinberg, R.A., and Lodish, H.F. (1992). Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68, 775-785.
22. Liu, J., Farmer, J.D., Jr., Lane, W.S., Friedman, J., Weissman, I., and Schreiber, S.L. (1991). Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66, 807-815.
23. Liu, J., Albers, M.W., Wandless, T.J., Alberg, D.G., Belshaw, P.J., Cohen, P., Mackintosh, C., Klee, C.B., and Schreiber, S.L. (1992). Inhibition of T cell signalling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry 31, 3896-3901.
24. Massagué, J., and Like, B. (1985). Cellular receptors for type b transforming growth factor: ligand binding and affinity labeling in human and rodent cell lines. J. Biol. Chem. 260, 2636-2645.
25. Massagué, J., Attisano, L., and Wrana, J.L. (1994). The TGF-β family and its composite receptors. Trends Cell Biol. 4, 172-178.
26. Mathews, L.S., and Vale, W.W. (1991). Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 65, 973-982.
27. Moses, H.L., Yang, E.Y., and Pietenpol, J.A. (1990). TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63, 245-247.
28. Price, J.M., Donahoe, P.K., and Hendren, W.H., III. (1977). Programmed cell death in the Müllerian duct induced by Müllerian Inhibiting Substance. Am. J. Anat. 149, 353-376.
29. Roberts, A.B., and Sporn, M.B. (1993). Physiological actions and clinical applications of transforming growth factor-β. Growth Factors 8, 1-9.
30. Sabatini, D.M., Erdjument-Bromage, J., Lui, M., Tempst, P., and Snyder, S.H. (1994). RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78, 35-43.
31. Schlessinger, J., and Ulrich, A. (1992). Growth factor signaling by receptor tyrosine kinases. Neuron 9, 383-391.
32. Siekierka, J.J., Hung, S.H.Y., Poe, M., Lin, C.S., and Sigal, N.H. (1989). A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature 341, 755-777.
33. Teixeira, J., He, W.W., Shah, P.C., Morikawa, N., Lee, M.M., Catlin, E.A., Hudson, P.L., Wing, J., Maclaughlin, D.T., and Donahoe, P.K. (1996) Developmental expression of a candidate Müllerian Inhibiting Substance type II receptor. Endocrinology 137, 160-165.
34. ten Dijke, P., Ichijo, H., Franzen, P., Schulz, P., Saras, J., Toyoshima, H., Heldin, C.H., Miyanzono, K. (1993). Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/ threonine kinase activity. Oncogene 8, 2879-2887.
35. ten Dijke, P., Yamashita, H., Ichijo, H., Franzen, P., Laiho, M., Miyazono, K., Heldin, C.H. (1994). Characterization of type I receptors for transforming growth factor-β and activin. Science 264, 101-104.
36. Trelstad, R.L., Hayashi, A., Hayashi, K., and Donahoe, P.K. (1982). The epithelial-mesenchymal interface of the male rat mullerian duct: loss of basement membrane integrity and ductal regression. Dev. Biol. 92, 27-40.
37. Wang, T.W., Donahoe, P.K., and Zervos, A.S. (1994). Specific interaction of type I receptors of the TGF-β family with the immunophilin FKBP12. Science 265, 674-676.
38. ras farnesyltransferase alpha subunit in TGF-β and activin signaling. Science 271, 1120-1122.
39. Weis-Garcia, F., and Massagué, J. (1996). Complementation between kinase-defective and activation-defective TGF-β receptors reveals a novel form of receptor cooperativity essential for signaling. EMBO J. 15, 276-289.
40. Wieser, R., Wrana, J.L., and Massagué, J. (1995). GS domain mutations that constitutively activate TGF-βR1, the downstream signaling component in the TGF-β receptor complex. EMBO J. 14, 2199-2208.
41. Wrana, J.L., Attisano, L., Carcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X.-F., and Massaqué, J. (1992). TGF-β signals through a heteromeric protein kinase receptor complex. Cell 71, 1003-1014.
42. Wrana, J.L., Attisano, L., Weiser, R., Ventura, F., and Massagué, J. (1994a). Mechanism of activation of the TGF-β receptor. Nature 370, 341-347.
43. Wrana, J.L., Tran, H., Attisano, L., Arora, K., Childs, S.R., Massagué, J., and O'Connor, M.B. (1994b). Two distinct transmembrane serine/threonine kinases from Drosophila melanogaster form an activin receptor complex. Mol. Cell. Biol. 14, 944-950.
44. Xie, T., Finelli, A.L., and Padgett, R.W. (1994). The Drosophila saxophone gene: a serine-threonine kinase receptor of the TGF-β super-family. Science 263, 1756-1759.
45. Yang, D., Rosen, M.K., and Schreiber, S.L. (1993). A composite FKBP12-FK506 surface that contacts calcineurin. J. Am. Chem. Soc. 115, 819-820.
46. Zervos, A.S., Gyuris, J., and Brent, R. (1993). Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72, 223-232.
47. Zheng, X.-F., Fiorentino, D., Chen, J., Crabtree, G.R., and Schreiber, S.L. (1995). TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin. Cell 82, 121-130.